Carbidopa (CD)
Showing 1 - 25 of 1,186
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Parkinson's Disease Trial in Worldwide (ND0612 (Levodopa/Carbidopa solution), ND0612 (Levodopa/Carbidopa solution) + morning
Completed
- Parkinson's Disease
- ND0612 (Levodopa/Carbidopa solution)
- ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CD
-
Chicago, Illinois
- +10 more
Feb 16, 2022
Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)
Completed
- Advanced Parkinson's Disease
-
Little Rock, Arkansas
- +10 more
May 11, 2022
Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,
Not yet recruiting
- Idiopathic Parkinson Disease
- levodopa/carbidopa oral formulation A
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Jul 20, 2022
Spinal Cord Injuries Trial in Bronx (CPH + hand training, CD-LD + hand training, ATX + hand training)
Recruiting
- Spinal Cord Injuries
- CPH + hand training
- +3 more
-
Bronx, New YorkJames J. Peters Veterans Affairs Medical Center
Jan 23, 2023
Parkinson's Disease Trial in Hayward (IPX066, IR CD-LD)
Idiopathic Parkinson's Disease Trial in Bingham Farms, Portland (IPX054 200 mg, IPX054 250 mg, CD-LD IR)
Completed
- Idiopathic Parkinson's Disease
- IPX054 200 mg
- +7 more
-
Bingham Farms, Michigan
- +1 more
Oct 25, 2019
Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)
Recruiting
- Chronic Pain
- Methylphenidate
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Jan 9, 2023
Parkinson's Disease (Disorder) Trial in Worldwide (IR CD-LD, IPX203 ER CD-LD, IPX203 )
Completed
- Parkinson's Disease (Disorder)
- IR CD-LD
- +3 more
-
Phoenix, Arizona
- +107 more
Jul 22, 2021
Parkinson's Disease Trial in West Bloomfield, Jerusalem, Tel Aviv (Levodopa and carbidopa SC solution, Oral levodopa and
Completed
- Parkinson's Disease
- Levodopa and carbidopa SC solution
- Oral levodopa and carbidopa
-
West Bloomfield, Michigan
- +2 more
Dec 9, 2019
Parkinson's Disease Trial in Chicago, Charleston (IPX054 200 mg, CD-LD IR, IPX054 Placebo)
Completed
- Parkinson's Disease
- IPX054 200 mg
- +3 more
-
Chicago, Illinois
- +1 more
Oct 25, 2019
Parkinson's Disease Trial in Italy, Luxembourg, Spain (continuous oral delivery of levodopa/carbidopa)
Recruiting
- Parkinson's Disease
- continuous oral delivery of levodopa/carbidopa
-
Cassino, Italy
- +3 more
Jul 20, 2021
Stroke Trial in Charlestown (Placebo, Levodopa / Carbidopa, Armeo)
Withdrawn
- Stroke
- Placebo
- +2 more
-
Charlestown, MassachusettsSpaulding Rehabilitation Hospital
Dec 17, 2021
Parkinson Disease Trial in Ahmedabad (WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS)
Recruiting
- Parkinson Disease
- WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS
-
Ahmedabad, IndiaLambda Therapeutic Research Ltd.
Sep 9, 2020
Exclusive Enteral Nutrition in Adult Active Crohn's Disease
Completed
- Crohn's Disease
- exclusive enteral nutrition treatment group
- (no location specified)
Apr 14, 2023
TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)
Not yet recruiting
- Crohn Disease
- Magnetic Resonance Enterography (MRE)
-
Liège, Belgium
- +17 more
Jun 5, 2023
Parkinson's Disease Trial in Novara (Probiotics, Placebo)
Enrolling by invitation
- Parkinson's Disease
- Probiotics
- Placebo
-
Novara, ItalyAzienda Ospedaliero-Universitaria "Maggiore della Carità"
Jun 9, 2022
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023